ARCHIVES

Wyden Hearing On Taxol Agreements Mangles Facts In Attempt To Protect ‘Public Interest’

This article is from The Cancer Letter archive.

Vol. 17 No. 32 | August 9, 1991

Download PDF Visit The Full Archive

Related Articles

Wider Use Of Adjuvant Chemotherapy Recommended By NIH Consensus Panel.

November 10, 2000

CR Funds Agencies At FY08 Level Through March 6.

October 3, 2008

Obituary: Joan Mauer, 65, Chief, NCI Clinical Trials Monitoring Branch

October 15, 2010

Low-Dose Warfarin Prevents Blood Clots, NIH Study Finds

February 28, 2003

Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers

April 25, 1980

Former FDA Commissioner Lester Crawford Pleads Guilty to Filing False Reports About His Ownership of Stocks in Health, Food, Biotech Companies.

October 20, 2006